Vaccitech plc - ADR
VACC
Get informed when a big investor buys or sells
+ FollowMarket Cap$192.73M
Close$
Share Statistics
| Market cap | $192.73 Million |
|---|---|
| Enterprise Value | $138.20 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.64 |
| Beta | -0.27 |
| Outstanding Shares | 40,848,893 |
Return
| Return on Equity | -78.78% |
|---|---|
| Return on Assets | -56.77% |
| Return on Invested Capital | -7.36% |
Valuation & Multiples
| P/E Ratio | -0.53 |
|---|---|
| PEG | 0.74 |
| Price to Sales | - |
| Price to Book Ratio | 5.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -23.43 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
April 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Vaccitech plc
2,021 employeesVaccitech is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. The company’s proprietary platf...